NCT00538850
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +260 more
- Locations
-
- InSys Therapeutics, Incorporated Chandler, Arizona, United States
Clinical trial condition
Sezary Syndrome
Explore clinical trials studying Sezary Syndrome. Study availability and eligibility vary by location and protocol.
262 public trials
17 recruiting studies
Sezary Syndrome trial results
NCT00438958
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +61 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
- Institute of Medical and Veterinary Science Adelaide, South Australia, Australia
- Royal Melbourne Hospital Parkville, Victoria, Australia
- Vancouver Hospital and Health Science Center Vancouver, British Columbia, Canada
NCT00499811
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- National Institutes of Health Bethesda, Maryland, United States
NCT00458731
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +116 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
NCT01273090
- Conditions
- Astrocytoma, Brain and Central Nervous System Tumors, Burkitt Lymphoma, +58 more
- Locations
-
- UAB Comprehensive Cancer Center Birmingham, Alabama, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
NCT00769288
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +107 more
- Locations
-
- Wayne State University Detroit, Michigan, United States
Completed
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
NCT01129180
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +35 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00293345
- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +107 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00005590
- Conditions
- Adnexal Diseases, Brain and Central Nervous System Tumors, Breast Cancer, +83 more
- Locations
-
- University of Birmingham Birmingham, England, United Kingdom
NCT00006340
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +47 more
- Locations
-
- Methodist Cancer Center at Methodist Hospital Indianapolis, Indiana, United States
- Cancer Research Center at Boston Medical Center Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Hopital Necker Paris, France